Email
Location
- Proof of concept (2026) — LiveRNA: Liver mRNA-based immunotherapies
- Proof of concept (2023) — S-CAMS: Spirocyclic CAMs as novel and ultrapotent anti-HBV drugs (S-CAM)
- Advanced (2023) — EUCLIDEAN: Acquired adaptive immune cell dysfunction and restoration in chronic hepatitis B
- Proof of concept (2020) — 2LIVEr: IL-2 gene therapy for chronic hepatitis B virus infection
- Consolidator (2016) — FATE: Functional Biology of Hepatic CD8+ T cells
- Starting (2010) — IVM-VIRUS-nAb: In vivo dynamics of antibody responses to lymph-borne viruses

